drugset / Trial / NCT04572516
Botulium Toxin Type A In Non Infectious Chronic Rhinosinusitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The present work aims to assess the effectiveness and safety of topical application of BTX - A compared with its intra turbinate injection in controlling the symptoms in non infectious chronic rhinosinusitis patients
Timeline
- Start
- 2020-05-01
- Primary completion
- 2021-06-15
- Completion
- 2021-07-15
Publications
- Background Zhang EZ, Tan S, Loh I. Botolinum toxin in rhinitis: Literature review and posterior nasal injection in allergic rhinitis. Laryngoscope. 2017 Nov;127(11):2447-2454. doi: 10.1002/lary.26616. Epub 2017 Jul 6.
- Background Ozcan C, Vayisoglu Y, Dogu O, Gorur K. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol. 2006 Sep-Oct;27(5):314-8. doi: 10.1016/j.amjoto.2006.01.008.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulium Toxin Type A | Unknown | 20 iu | Topical |